Analyze the related genes and clinical therapy of MRKH syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025238

Enrollment

Unknown

Registered

2019-08-17

Start date

2019-08-15

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRKH syndrome

Interventions

MRKH syndrome:none

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. the absence of the vagina or two-thirds of the upper vagina; 2. without uterus or with primordial uterus; 3. normal ovary and fallopian tubes; 4. a 46 XX karyotype; 5. Normal female secondary sexuality

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
gene mutation;	—

Countries

China

Contacts

Public ContactXueqiong Zhu

The Second Affiliated Hospital of Wenzhou Medical University

zjwzzxq@163.com+86 13906640759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026